Wisconsin Collaborative for Quality Healthcare

View Our Reports

print this page
Your Search Results: 14 Clinics in the Mayo Eau Claire health system


The results below represent the care of 5,687 patients with Diabetes. Read More About This Measure

Reporting Period:

Sort By Rank | Sort By Name  
Btn Export
CLINIC_NAME

The number of patients or providers is too small for
purposes of reliably reporting performance
Mayo Clinic Health System - Chippewa Valley in Bloomer
N=334
86.23 %
View Historical Data
Mayo Clinic Health System - Chippewa Valley in Chippewa Falls
N=609
89.33 %
View Historical Data
Mayo Clinic Health System - Northland in Barron
N=386
88.08 %
View Historical Data
Mayo Clinic Health System - Northland in Cameron

The number of patients or providers is too small for
purposes of reliably reporting performance
Mayo Clinic Health System - Northland in Chetek

The number of patients or providers is too small for
purposes of reliably reporting performance
Mayo Clinic Health System - Northland in Rice Lake
N=266
79.70 %
View Historical Data
Mayo Clinic Health System - Oakridge in Mondovi
N=179
87.15 %
View Historical Data
Mayo Clinic Health System - Oakridge in Osseo
N=206
83.01 %
View Historical Data
Mayo Clinic Health System - Red Cedar in Elmwood

The number of patients or providers is too small for
purposes of reliably reporting performance
Mayo Clinic Health System - Red Cedar in Glenwood City
N=143
81.12 %
View Historical Data
Mayo Clinic Health System - Red Cedar in Menomonie
N=1072
87.31 %
View Historical Data
Mayo Clinic Health System in Eau Claire (Clairemont Campus)
N=1662
86.52 %
View Historical Data
Mayo Clinic Health System in Eau Claire (Luther Campus)
N=830
88.07 %
View Historical Data

In November 2013, The American College of Cardiology/American Heart Association (ACC/AHA) Task Force on Practice Guidelines released updated guidance for the treatment of blood cholesterol. The new recommendations remove treatment targets for LDL-C for the primary or secondary prevention of atherosclerotic cardiovascular disease (ASCVD) and recommend high or moderate intensity statin therapy based on patient risk factors. Four major stain benefit groups were identified and diabetics age 40 to 75 years, regardless of LDL-C level and without clinical ASCVD are one of the identified groups.


Disclaimer: Measures reported by WCHQ healthcare organizations represent a specific aspect of care in relation to an evidence-based standard, but are not clinical guidelines and do not establish standards of care.